HCA Healthcare (NYSE:HCA) PT Raised to $400.00 at Oppenheimer

HCA Healthcare (NYSE:HCA) had its price target raised by equities research analysts at Oppenheimer from $390.00 to $400.00 in a report issued on Monday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price objective indicates a potential upside of 10.88% from the stock’s current price.

Other analysts have also issued reports about the company. Barclays raised their price objective on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. UBS Group lifted their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Morgan Stanley started coverage on HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective for the company. Finally, Royal Bank of Canada boosted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $379.11.

HCA Healthcare Stock Performance

NYSE:HCA opened at $360.75 on Monday. The stock’s 50-day simple moving average is $394.42 and its 200 day simple moving average is $353.21. The firm has a market capitalization of $94.49 billion, a PE ratio of 17.98, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare has a twelve month low of $222.23 and a twelve month high of $417.14.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Several hedge funds have recently made changes to their positions in HCA. Capital World Investors raised its stake in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares during the period. Lee Danner & Bass Inc. bought a new stake in shares of HCA Healthcare in the second quarter valued at $131,527,000. Darsana Capital Partners LP raised its stake in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares during the period. Swedbank AB bought a new stake in shares of HCA Healthcare in the first quarter valued at $95,882,000. Finally, TD Asset Management Inc raised its stake in shares of HCA Healthcare by 30.4% during the 1st quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock valued at $240,581,000 after purchasing an additional 168,093 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.